Final answer:
Compared to other sedatives used in the ICU, continuously administered benzos are associated with risks such as withdrawal syndrome, tolerance, dependence, and cognitive and behavioral adverse effects.
Step-by-step explanation:
Compared with sedatives used in the Intensive Care Unit (ICU) such as dexmedetomidine or propofol, continuously administered benzodiazepines (benzos) are associated with certain risks and adverse effects.
One of the risks is the potential for benzodiazepine withdrawal and rebound syndrome if the drugs are rapidly discontinued. Tolerance and dependence may also occur with continuous use of benzodiazepines.
Furthermore, benzos have a higher risk of cognitive and behavioral adverse effects compared to other sedatives. However, the risk of abuse with benzodiazepines is smaller than that of barbiturates.